Editorial
Treatment of limited-stage small cell lung cancer in the elderly, chemotherapy vs. sequential chemoradiotherapy vs. concurrent chemoradiotherapy: that’s the question
Translational Lung Cancer Research
2016;
5
(2)
:150-154
.
(28 April 2016)
Review Articles on Non-Small Cell Lung Cancer1
Epigenetics in non-small cell lung cancer: from basics to therapeutics
Translational Lung Cancer Research
2016;
5
(2)
:155-171
.
(28 April 2016)
The role of epithelial to mesenchymal transition in resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
Translational Lung Cancer Research
2016;
5
(2)
:172-182
.
(28 April 2016)
Is surgery still the optimal treatment for stage I non-small cell lung cancer?
Translational Lung Cancer Research
2016;
5
(2)
:183-189
.
(28 April 2016)
Controversies on Lung Cancer: Pros and Cons (Section Chairs: Suresh Senan, Helmut H. Popper)2
Pros: concurrent chemo-radiotherapy remains the ideal treatment in fit patients with large volume unresectable stage III non-small cell lung cancer
Translational Lung Cancer Research
2016;
5
(2)
:190-194
.
(28 April 2016)
Cons: concurrent chemo-radiotherapy remains the ideal treatment in fit patients with inoperable large volume stage III non-small cell lung cancer
Translational Lung Cancer Research
2016;
5
(2)
:195-197
.
(28 April 2016)
Rebuttal from Prof. Kong and Dr. Rabatic
Translational Lung Cancer Research
2016;
5
(2)
:198-200
.
(28 April 2016)
Rebuttal from Prof. Rodrigues
Translational Lung Cancer Research
2016;
5
(2)
:201
.
(28 April 2016)
Evidence-Based Medicine3
Prognostic value of the expression of estrogen receptor β in patients with non-small cell lung cancer: a meta-analysis
Translational Lung Cancer Research
2016;
5
(2)
:202-207
.
(28 April 2016)
Commentary
Erlotinib plus concurrent whole-brain radiation therapy for non-small cell lung cancers patients with multiple brain metastases
Translational Lung Cancer Research
2016;
5
(2)
:208-211
.
(28 April 2016)
News
Translational Lung Cancer Research is endorsed by the Brazilian Society of Thoracic Surgery
Translational Lung Cancer Research
2016;
5
(2)
:212
.
(28 April 2016)
Retraction
Retraction to platelets and their role in cancer evolution and immune system
Translational Lung Cancer Research
2016;
5
(2)
:213
.
(28 April 2016)
Disclosure:
1. The series “Non-Small Cell Lung Cancer” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.
2. The series “Controversies on Lung Cancer: Pros and Cons” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Suresh Senan and Helmut H. Popper served as the unpaid Guest Editors for the series.
3. The series “Evidence-Based Medicine” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.
